Xenetic Biosciences Inc. (XBIO)
4.00
0.08 (2.04%)
At close: Mar 03, 2025, 3:38 PM
4.06
1.50%
After-hours: Mar 03, 2025, 03:24 PM EST
Xenetic Biosciences Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 8.98M | 13.1M | 18.24M | 11.53M | 10.37M | 571.61K | 5.53M | 4.05M | 132.23K | 2.51M | 4.84M | 11.14M | 10K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 1.02M | 1.07M | 1.09M | 782.94K | 1.21M | 705.66K | 724.71K | 66.34K | 129.31K | 199.27K | n/a | -13.83M | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3M | n/a | 115.78K | 256.01K | 212.18K | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 603.83K | 556.09K | 252.36K | 225K | 195K | 622.37K | 351.51K | 1.29M | 4.06M | 88.24K | 234.31K | 195.91K | n/a |
| Total Current Assets | 9.59M | 13.65M | 18.72M | 12.37M | 11.09M | 1.19M | 5.88M | 8.34M | 4.19M | 2.78M | 5.33M | 11.54M | 10K |
| Property-Plant & Equipment | n/a | n/a | n/a | 27.04K | 757.00 | 4.96K | 27.85K | 42.37K | 62.02K | 119.45K | 152.6K | 122.08K | 212.5K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | 9.24M | 12.53M | 12.53M | 12.53M | 12.53M | 13.22M | 13.98M | 13.7M | n/a |
| Total Long-Term Assets | 1.02M | 1.07M | 1.09M | 809.99K | 10.46M | 13.24M | 13.28M | 12.64M | 12.72M | 13.54M | 14.14M | 13.83M | 212.5K |
| Total Assets | 10.61M | 14.72M | 19.82M | 13.18M | 21.55M | 14.43M | 19.16M | 20.97M | 16.91M | 16.32M | 19.47M | 25.37M | 222.5K |
| Account Payables | 240.83K | 287.36K | 362.47K | 327.4K | 931.13K | 934.15K | 786.78K | 1.01M | 1.79M | 852.76K | 942.16K | 119.67K | 7.37K |
| Deferred Revenue | n/a | n/a | -27.04K | -35.48K | -20.04K | n/a | n/a | n/a | 1.49M | -395K | 1.91M | 543.34K | n/a |
| Short-Term Debt | n/a | n/a | 27.04K | n/a | n/a | n/a | n/a | n/a | 4.05M | 395K | 681.12K | 682.99K | n/a |
| Other Current Liabilities | 568.75K | 785.8K | 1.03M | 609.53K | 484.03K | 665.64K | 1.16M | 859.09K | 1.51M | 1.45M | 1.88M | 510.4K | 548.00 |
| Total Current Liabilities | 809.59K | 1.07M | 1.42M | 936.93K | 1.42M | 1.6M | 1.94M | 1.87M | 7.34M | 2.7M | 3.59M | 1.4M | 7.92K |
| Long-Term Debt | n/a | n/a | n/a | 27.04K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 212.81K | 212.81K |
| Other Long-Term Liabilities | n/a | n/a | n/a | -27.04K | n/a | n/a | n/a | 19.88K | 38.79K | 56.38K | n/a | -212.81K | n/a |
| Total Long-Term Liabilities | n/a | 287.36K | n/a | 27.04K | 2.92M | 2.92M | 2.92M | 2.94M | 2.96M | 3.14M | 3.26M | 3.19M | 212.81K |
| Total Liabilities | 809.59K | 1.07M | 1.42M | 963.97K | 4.33M | 4.52M | 4.86M | 4.8M | 10.3M | 5.84M | 6.85M | 4.59M | 220.74K |
| Total Debt | n/a | n/a | 27.04K | 62.52K | 20.04K | n/a | n/a | n/a | 395K | 395K | 681.12K | 682.99K | 212.81K |
| Common Stock | 1.54K | 15.19K | 13.46K | 8.77K | 6.09K | 9.73K | 9.04K | 8.73K | 162.01K | 1.5M | 1.31M | 1.31M | 10K |
| Retained Earnings | -193.23M | -189.1M | -182.55M | -176.9M | -166.01M | -153.23M | -145.93M | -142.34M | -88.13M | -75.62M | -58.31M | -49.73M | -8.23K |
| Comprehensive Income | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 575.68K | 900.25K | 915.6K | n/a |
| Shareholders Equity | 9.8M | 13.65M | 18.39M | 12.22M | 17.21M | 9.91M | 14.3M | 16.17M | 6.61M | 10.48M | 12.62M | 20.78M | 1.76K |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |